Pharmaceutical Immunotoxicity

Pharmaceutical Immunotoxicity is an academic concept referring to the adverse effects of pharmaceutical agents on the immune system of aquatic organisms, distinguished from other forms of immunotoxicity by its specificity to bioactive compounds introduced into aquatic environments through human or veterinary medical use.

52

Publications

1.5K

Citations

192

Authors

90

Institutions

Publications per year

2017–2026

2

Authors

192

  1. KL
    Kenneth L. Hastings

    United States Food and Drug Administration, United States

    4 publications · 65 citations

    4

    h-index

  2. HV
    Henk Van Loveren

    National Institute for Public Health and the Environment, Netherlands

    4 publications · 96 citations

    4

    h-index

  3. HL
    Hervé Lebrec

    Amgen (United States), United States

    3 publications · 68 citations

    3

    h-index

  4. TT
    Thomas T. Kawabata

    Pfizer (United States), United States

    3 publications · 55 citations

    3

    h-index

  5. JH
    Jack H. Dean

    Research Triangle Park Foundation, United States

    3 publications · 78 citations

    3

    h-index

1–5 of 192

Venues

  1. Toxicology

    7 publications · 186 citations

    7

    h-index

  2. Journal of Immunotoxicology

    4 publications · 74 citations

    4

    h-index

  3. Fundamental and Applied Toxicology

    3 publications · 55 citations

    3

    h-index

  4. Food and Chemical Toxicology

    3 publications · 178 citations

    3

    h-index

  5. PubMed

    Repository · 3 publications · 58 citations

    3

    h-index

1–5